Featured Research

from universities, journals, and other organizations

TLR proteins can provide security from tissue destruction

Date:
January 19, 2010
Source:
Journal of Clinical Investigation
Summary:
TLRs are best known for their role in triggering an inflammatory response upon recognition of microbial products. However, they also initiate inflammatory responses, thereby amplifying tissue destruction, upon binding damage-associated molecular patterns (DAMPs), molecules released by cells damaged under sterile conditions. Researchers have now determined in mice that TLR recognition of DAMPs also triggers a response that protects from excessive tissue damage.

TLRs are best known for their role in triggering an inflammatory response upon recognition of microbial products. However, they also initiate inflammatory responses, thereby amplifying tissue destruction, upon binding damage-associated molecular patterns (DAMPs), molecules released by cells damaged under sterile conditions.

A team of researchers at Memorial Sloan-Kettering Cancer Center, New York, has now determined in mice that TLR recognition of DAMPs also triggers a response that protects from excessive tissue damage.

The team, led by Ronald DeMatteo studied a mouse model of sterile inflammation in which liver damage was caused by temporarily restricting blood flow to the liver. Liver damage was increased in this model of sterile inflammation by prior depletion of immune cells known as conventional DCs (cDCs). Further in vitro and in vivo analysis indicated that cDCs produced the antiinflammatory molecule IL-10 in response to TLR9 recognition of liver cell DNA and that this was crucial to their ability to reduce liver damage in the model of sterile inflammation.

The authors therefore suggest that it might be possible to reduce tissue damage caused by temporary restriction of blood flow (something that occurs often in surgery) by harnessing the antiinflammatory potential of cDCs via TLR9.

The research appears in the Journal of Clinical Investigation.



Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Journal Reference:

  1. Zubin M. Bamboat, Lee M. Ocuin, Vinod P. Balachandran, Hebroon Obaid, George Plitas and Ronald P. DeMatteo. Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion. Journal of Clinical Investigation, 2010; DOI: 10.1172/JCI40008

Cite This Page:

Journal of Clinical Investigation. "TLR proteins can provide security from tissue destruction." ScienceDaily. ScienceDaily, 19 January 2010. <www.sciencedaily.com/releases/2010/01/100119224734.htm>.
Journal of Clinical Investigation. (2010, January 19). TLR proteins can provide security from tissue destruction. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2010/01/100119224734.htm
Journal of Clinical Investigation. "TLR proteins can provide security from tissue destruction." ScienceDaily. www.sciencedaily.com/releases/2010/01/100119224734.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins